LF

LifeStance Health Group, Inc.

LFSTHealthcareNASDAQ

Medical Care Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.42B
+13.9% YoY
Net Income
$9.7M
+116.8% YoY
EBITDA
$78.8M
+97.6% YoY
Free Cash Flow
$140.7M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OverboughtRSI 72.7, above 70, stock may be overbought
Jul 10 RSI OverboughtRSI 76.9, above 70, stock may be overbought
About LifeStance Health Group, Inc.

Part of the healthcare sector, LifeStance Health Group, Inc. (LFST) is listed under Medical Care Facilities. The company carries a $4.42B market cap, placing it firmly in the mid-cap category. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Key stats
Market Cap$4.42B
P/E (TTM)193.00
Fwd P/E29.54
EPS$0.06
Beta1.12
52W Change+174.4%
ROE1.6%
Analysis

The company holds $194.8M in cash, though total debt stands at $476.8M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $140.7M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 1.6% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 1.4% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $859.5M (2022) to $1.42B (2025), reflecting a 66% increase over the period.

At over 50x earnings, LFST carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. No single metric tells the full story. Reviewing LFST's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms